More private payers to cover tibial nerve stimulation

Article

Uroplasty, Inc. (Minneapolis) has announced that two additional private insurance payers will cover posterior tibial nerve stimulation (PTNS) using its Urgent PC Neuromodulation System for the treatment of overactive bladder and associated symptoms.

Uroplasty, Inc. (Minneapolis) has announced that two additional private insurance payers will cover posterior tibial nerve stimulation (PTNS) using its Urgent PC Neuromodulation System for the treatment of overactive bladder and associated symptoms.

Effective Aug. 1, 2011, Health Care Service Corp. will begin covering and paying for PTNS therapy for patients in Texas, Illinois, New Mexico, and Oklahoma. Additionally, effective May 18, 2011, BlueCross BlueShield of Nebraska initiated coverage of PTNS treatments.

"We have now secured coverage from three of the four largest private payers in the United States," said David Kaysen, president and CEO of Uroplasty. "We estimate that in total, the Medicare and private-pay carriers that today provide coverage for PTNS treatments represent approximately 115 million lives."

Recent Videos
Kelly L. Stratton, MD, FACS, answers a question during a Zoom video interview
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
DNA | Image Credit: © BillionPhotos.com - stock.adobe.com
Kyrollis Attalla, MD, an expert on prostate cancer
Kyrollis Attalla, MD, an expert on prostate cancer
Blurred interior of hospital | Image Credit: © jakkapan - stock.adobe.com
Quitting smoking - male hand crushing cigarette | Image Credit: © mbruxelle - stock.adobe.com
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.